Human Gut Commensal Bacteroides fragilis Suppresses Mucin Production and Alters Microbiota Composition Resulting in Accelerated Type 1 Diabetes in Mice
Immunology · 2026
DOI: 10.1111/imm.70032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Radhika R Gudi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Immunology, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Bacteroides fragilis, Gastrointestinal Microbiome, Diabetes Mellitus, Type 1, Mucins. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes (T1D) in humans is associated with a higher Bacteroidetes:Firmicutes ratio and a higher abundance of Bacteroides genus members. Bacteroides fragilis (BF) is an integral component of the human colonic commensal microbiota. Here, we show that gut colonisation of specific pathogen‐free (SPF) non‐obese diabetic (NOD) mice by BF at a juvenile age induces a pro‐inflammatory immune response and accelerated disease progression. NOD mice born to BF‐monocolonised parents not only showed rapid disease progression compared to germ‐free (GF) controls but also preserved accelerated disease onset and higher disease incidence upon conventionalisation, suggesting that BF contributes to a pro‐inflammatory response and autoimmunity in T1D. Interestingly, we found that while gut microbiota composition was different in control and BF‐colonised SPF mice, the presence of BF alone could significantly impact the acquisition of microbial communities upon conventionalisation of gnotobiotic mice. Bulk RNAseq analysis of colon tissues revealed profound differences in the gene expression pattern of GF and BF‐monocolonised mice as well as their conventionalised counterparts, shedding light on the probable mechanisms contributing to accelerated disease onset in mice that are exposed to BF. We found that mucin production is downregulated and the abundance of mucin degraders such as Akkermansia muciniphila is profoundly lower in BF‐colonised mice. Overall, these studies demonstrate that early life acquisition of BF‐like distal gut commensals could have profound modulatory effects on the eventual overall gut physiology, microbiota structure, immune function, and β‐cell specific autoimmune outcomes under genetic susceptibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology and Immunology, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Biomedical & Community Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
ORCID-Profile: Chenthamarakshan Vasu
Förderung
- NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Gudi, R. R., Taylor, H., Johnson, B. M., Maurya, R., Mulligan, M. E., Carter, L., Westwater, C., & Vasu, C. (2026). Human Gut Commensal Bacteroides fragilis Suppresses Mucin Production and Alters Microbiota Composition Resulting in Accelerated Type 1 Diabetes in Mice. Immunology. https://doi.org/10.1111/imm.70032
Vancouver
Gudi RR, Taylor H, Johnson BM, Maurya R, Mulligan ME, Carter L, et al. Human Gut Commensal Bacteroides fragilis Suppresses Mucin Production and Alters Microbiota Composition Resulting in Accelerated Type 1 Diabetes in Mice. Immunology. 2026. doi:10.1111/imm.70032
BibTeX
@article{Gudi2026,
author = {Gudi, Radhika R and Taylor, Harrison and Johnson, Benjamin M and Maurya, Ruchika and Mulligan, Mary E and Carter, Loni and Westwater, Caroline and Vasu, Chenthamarakshan},
title = {Human Gut Commensal Bacteroides fragilis Suppresses Mucin Production and Alters Microbiota Composition Resulting in Accelerated Type 1 Diabetes in Mice},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70032}
}
EUVIMED